Meeting Report
Other Solid Cancers: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner
Elizabeth S. Waxman,(1) RN, MSN, AOCN®, ANP-BC, and Abby Fuoto,(2) DNP, ANP-BC, AOCNP®, ACHPN
(1) MD Anderson Cancer Center; (2) University of Arizona Cancer Center
J Adv Pract Oncol 2020;11(6):612-615 |
https://doi.org/10.6004/jadpro.2020.11.6.9 |
© 2020 Harborside™
ABSTRACT
Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC, of MD Anderson Cancer Center, evaluates a study showing activity by pralsetinib in patients with a variety of tumors harboring RET gene fusions, and Abby Fuoto, DNP, ANP-BC, AOCNP®, ACHPN, of University of Arizona Cancer Center, comments on the effect of deintensification in patients with intermediate-risk HPV-positive oropharyngeal cancer. Meeting coverage is provided by The ASCO Post.
For access to the full length article, please
sign in.
